A. Fitzgerald

发表

Rapid responses to anakinra in patients with refractory adult-onset Still's disease.

C. Dinarello, S. Leclercq, J. Homik, 2005, Arthritis and rheumatism.

Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis.

M. Suarez‐Almazor, J. A. Aviña-Zubieta, A. Russell, 1997, The Journal of rheumatology.

A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis.

M. Suarez‐Almazor, A. Russell, A. Fitzgerald, 1988, The Journal of rheumatology.

Early Management of Newly Diagnosed Rheumatoid Arthritis by Canadian Rheumatologists: A National, Multicenter, Retrospective Cohort

A. Laupacis, C. Bombardier, G. Tomlinson, 2011, The Journal of Rheumatology.

Case studies in osteoporosis: a problem based learning intervention for family physicians.

M. Suarez‐Almazor, B. Kvern, A. Russell, 1999, The Journal of rheumatology.

The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation.

C. Barnabe, S. Leclercq, A. Fitzgerald, 2009, Seminars in arthritis and rheumatism.

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.

G. Jhangri, S. Leclercq, J. Homik, 2002, Arthritis and rheumatism.

Relative urgency for referral from primary care to rheumatologists: The Priority Referral Score

Tom Noseworthy, Gillian Hawker, Diane Lacaille, 2011, Arthritis care & research.

Priority-setting tools for rheumatology disease referrals: a review of the literature

M. Cepoiu, C. Coster, A. Fitzgerald, 2008, Clinical Rheumatology.

A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.

J. Esdaile, J. Canvin, A. Fitzgerald, 2005, Arthritis and rheumatism.

Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.

C. Bombardier, J. Esdaile, M. Fitzcharles, 2000, The Journal of rheumatology.

A comparison of flurbiprofen and naproxen in the treatment of rheumatoid arthritis: a Canadian multi-centre study.

W. Buchanan, H. Tannenbaum, A. Fitzgerald, 1990, Current medical research and opinion.

Time to Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis and Its Predictors: A National, Multicenter, Retrospective Cohort

A. Laupacis, C. Bombardier, G. Tomlinson, 2012, The Journal of Rheumatology.

Clinical evaluation of a new controlled-release formulation of naproxen in osteoarthritis and rheumatoid arthritis

N. Bellamy, W. Buchanan, P. Corey, 1988 .